(Q43476840)

English

Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease

scientific article published on 4 December 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Alessandro Allegra

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Mirella Profita

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sebastiano Gangemi

9

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

object named as

Anna Bonanno

7

0 references

4

object named as

Andrea Alonci

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Caterina Musolino

1

object named as

Caterina Musolino

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

6

object named as

Sabina Russo

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

8

object named as

Vanessa Innao

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Salvatore Saitta

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

4 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

160

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

709-710

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

IL-33: a novel danger signal system in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12146

21 January 2018

Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12146

21 January 2018

Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12146

21 January 2018

Dysfunctional T regulatory cells in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12146

21 January 2018

Immunodeficiency and immunotherapy in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12146

21 January 2018

Dendritic cell vaccine but not idiotype-KLH protein vaccine primes therapeutic tumor-specific immunity against multiple myeloma.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12146

21 January 2018

Identifiers

10.1111/BJH.12146

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43476840&oldid=2194391399"